Catatonia and Schizophrenia in a Young Man with Autism Spectrum Disorder and Clozapine-Induced Myocarditis
Authors:
- Mohan GautamMGMohan Gautam
- Mauran SivananthanMSMauran Sivananthan
- Robert CotesRCRobert Cotes
- Scott BeachSBScott Beach
- 14 April 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Harvard Review of Psychiatry
- Vol. 30 (4) , 261-269
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analysesCNS Spectrums, 2012
- A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 ControlsAustralian & New Zealand Journal of Psychiatry, 2011
- Metformin for olanzapine‐induced weight gain: a systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2011
- Cardiovascular magnetic resonance in mild to moderate clozapine‐induced myocarditis: Is there a role in the absence of electrocardiographic and echocardiographic abnormalities?Journal of Magnetic Resonance Imaging, 2010
- Treatment of Catatonia With Olanzapine and AmantadinePsychosomatics, 2007
- Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomenaNeuroscience & Biobehavioral Reviews, 2007
- Some biological correlates of drug resistance in schizophrenia: A multidimensional approachThe World Journal of Biological Psychiatry, 2005
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesObesity Research, 2004
- Synergism of lorazepam and electroconvulsive therapy in the treatment of catatoniaBiological Psychiatry, 1997
- Prazepam and Lorazepam, Two New BenzodiazepinesNew England Journal of Medicine, 1978